Friday, February 3, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Purchase DME
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Purchase DME
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Co-opting Price Transparency

Jay K Joshi by Jay K Joshi
September 6, 2021
in Politics & Law
0

Rome ceased to be Rome when the Emperors ceased to rule.

When the Emperors became figureheads for ambitious generals and scheming politicians, Rome was no longer Rome.

An empire built upon the strength of a philosopher king, a man of the Republic, first among equals, then transformed into a bureaucracy rife with duplicity and intrigue.

The long fall of Rome is filled with such stories, in which principles and ideals gave way to politics and corruption. The term byzantine, which historians use to describe the latter centuries of Rome, a period marked by such transformation, is also used to characterize someone or something as deceiving and cunning.

The term can also apply to how the medical issue of price transparency has been co-opted by the legal industry.

Originally proposed during the Trump presidency by the former administrator of the Centers for Medicare and Medicaid Services, Miss Seema Verma, the goal was to empower patients by making the price of drugs and clinical services available to the public. Miss Verma wrote an op-ed in 2019 describing her position – “You wouldn’t buy a car without knowing the price. So why are health care prices hidden?”

Her rationale was that price transparency helped patients make informed purchasing decisions about their health. Her rationale was ideal, but proved to be wrong.

Patients, once given the financial data, had little ability to make sense of it, and simply resumed receiving clinical care at healthcare institutions they were familiar with. It would appear that calculating the cost of care is a bit more complex than purchasing a car.

And with all things complex, there are unintended consequences. The push for price transparency came with its own documentation requirements in listing the prices. Some institutions were more forthright than others. Some institutions contextualized costs selectively in order to make certain aspects of care seem cheaper than their competitors.

Medicare responded by threatening sanctions and lawsuits against healthcare institutions that gamed the system or failed to participate entirely. The institutions and their lobbying organizations responded with lawsuits of their own. And so the transformation began.

The goal of transparency transformed into a burden of documentation.

The first and most prominent example being the lawsuit in which the American Hospital Association (AHA) sued the Department of Health and Human Services (DHHS). The AHA eventually lost, even after appeals, when the appellate court ruled:

“The [American Hospital Association] does not dispute that the government has a legitimate interest in promoting price transparency and lowering healthcare costs. Instead, it contends that the rule bears no reasonable relationship to those governmental interests because the required disclosures ‘may not be immediately or directly useful for many health care consumers,’” the judge wrote. “But…the secretary, relying on complaints from consumers, studies of state initiatives, and analysis of industry practices, reasonably concluded that the rule’s disclosure scheme will help the vast majority of consumers.”

The AHA argued that price transparency does not help patients make clinical decisions. But the courts, relying on consumer complaints and government reports, ruled otherwise.

Interestingly, the AHA was right. Price transparency does not influence patient decision-making as to where they choose to receive clinical care. Something verified repeatedly in recent clinical studies.

But in transforming patients into consumers, both the AHA and DHHS miss the mark – patient care cannot be understood through traditional consumerism principles. In fact, neither side discussed how patients would use the data. They just erroneously assumed patients make decisions like consumers.

The ruling paved the way for the legal industry to enter, further transforming the policy away from its original intentions and creating a new venue for legal liability.

Now healthcare institutions face legal liability based upon their reporting standards, regardless of whether patients use the pricing data.

And the legal arguments center on the extent to which institutions must report their prices. A few days ago, the U.S. Chamber of Commerce and a Texas affiliate withdrew a suit that would have blocked certain parts of the required price disclosures. This came in response to a decision by the Biden administration to defer certain price disclosures which were the focus of the suit.

The suit hardly mentions anything about patient decision-making. It only focuses on the documentation burdens coming from price disclosures.

The Pharmaceutical Care Management Association (PCMA) has also filed a lawsuit against the DHHS on similar grounds of documentation burdens. And many more lawsuits will be filed once all the provisions within the price transparency rule come into effect in 2022.

This would complete the transformation, changing an idealistic medical policy – intended to empower patients – into a legal liability to be adjudicated ad nauseam in the court of law.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Malicious Prosecution and Fabrication of Evidence

    Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • 2022 Letter to the American Medical Association

    0 shares
    Share 0 Tweet 0
  • 2023 Letter to the American Medical Association

    0 shares
    Share 0 Tweet 0
  • Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do